Crinetics Pharmaceuticals (CRNX) Revenue Growth (3y) (2020 - 2026)
Crinetics Pharmaceuticals (CRNX) Revenue Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | - |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn | 50.07% |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn | 7.94% |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn | 4.47% |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | - |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn | 79.44% |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn | 54.05% |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - | - |
| 10 | Crinetics Pharmaceuticals | 8.73 Bn | 7.44 Bn | 10.53 Mn | 58.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.83% |
| Dec 31, 2025 | 105.59% |
| Sep 30, 2025 | -32.16% |
| Jun 30, 2025 | 32.92% |
| Mar 31, 2025 | -51.33% |
| Mar 31, 2023 | 235.41% |
| Dec 31, 2022 | 30.23% |
| Sep 30, 2022 | -3.20% |
| Mar 31, 2022 | 104.33% |
| Dec 31, 2021 | 11.34% |
| Dec 31, 2020 | -28.75% |